Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT for Actinic Keratoses on Upper Extremities
NCT02137785Phase 3Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- May 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by DUSA Pharmaceuticals. Started May 2014; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02137785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137785.